AU636066B2 — Thienoimidazole derivatives, their production and use
Assigned to Takeda Pharmaceutical Co Ltd · Expires 1993-04-08 · 33y expired
What this patent protects
Benzimidazole derivatives of the formula (I): <CHEM> wherein the ring A is a thiophene ring which may optionally contain substitution in addition to the R<3> group; R<1> is hydrogen or optionally substituted hydrocarbon residue which may be bonded through a hete…
USPTO Abstract
Benzimidazole derivatives of the formula (I): <CHEM> wherein the ring A is a thiophene ring which may optionally contain substitution in addition to the R<3> group; R<1> is hydrogen or optionally substituted hydrocarbon residue which may be bonded through a hetero atom; R<2> and R<3> are independently a group capable of forming an anion or a group convertible thereinto; X is a direct bond or a spacer having an atomic length of two or less between the phenylene group and the phenyl group; and n is an integer of 1 or 2; or a salt thereof, have potent angiotensin II antagonistic activity and antihypertensive activity, thus being useful as therapeutic agents for treating circulatory system diseases such as hypertensive diseases, heart diseases (e.g. hypercardia, heart failure, cardiac infarction, etc.), strokes, cerebral apoplexy, nephritis, etc.
Drugs covered by this patent
- Trulance (PLECANATIDE) · Salix
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.